BRCA1 and ovarian neoplasm: The present study is the first investigating somatic TP53 mutations in ovarian tumors from carries of two distinct high penetrant BRCA1 germ-line mutations, relating it to survival and age at diagnosis of disease and compares it to sporadic cases.